Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 02/08 03:59:59 pm
390.53 USD   -1.53%
10:16a UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's
02/02 REGENERON PHARM : Announces Upcoming 2016 Investor Conference Presen..
01/28DJAmgen Profit Rises 39%; 2016 Outlook Raised
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
React to this article
Latest news on REGENERON PHARMACEUTICALS
10:16a UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's
02/02 REGENERON PHARMACEUTICALS : Amendments to Articles of Inc. or Bylaws; Change in ..
02/02 REGENERON PHARMACEUTICALS : Announces Upcoming 2016 Investor Conference Presenta..
01/28DJAmgen Profit Rises 39%; 2016 Outlook Raised
01/28DJAmgen Profit Rises 39%; 2016 Outlook Raised
01/27 REGENERON PHARMACEUTICALS : Studies from Regeneron Pharmaceuticals Inc. in the A..
01/27 REGENERON PHARMACEUTICALS : Patent Issued for Stabilized Formulations Containing..
01/26 NASDAQ 100 MOVERS : Incy, sbac
01/26 REGENERON PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2015 Financia..
01/14 REGENERON PHARMACEUTICALS : Announces Presentation at the 34th Annual J.P. Morga..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials